Build with KISHO Sign In Sign Up

Kisho

Bioverativ Therapeutics, Inc. — Rare Disease Pipeline | Kisho | Kisho

Bioverativ Therapeutics, Inc.

Other

3

Orphan Designations

0

FDA Approvals

15

Rare Diseases

0

News Articles

Disease	Drug(s)	Designation	Approved
RFT1-congenital disorder of glycosylation	ALPROLIX	Orphan Designation	-
Stormorken syndrome	ALPROLIX	Orphan Designation	-
autism	Eloctate	Orphan Designation	-
bleeding disorder, platelet-type, 21	AltuviiioEloctate	Orphan Designation	-
bleeding disorder, platelet-type, 22	AltuviiioEloctateALPROLIX	Orphan Designation	-
bleeding disorder, platelet-type, 25	AltuviiioEloctate	Orphan Designation	-
hemophilia A	AltuviiioEloctate	Orphan Designation	-
intellectual developmental disorder, X-linked, syndromic, Pilorge type	Eloctate	Orphan Designation	-
intellectual disability-severe speech delay-mild dysmorphism syndrome	EloctateALPROLIX	Orphan Designation	-
lysinuric protein intolerance	ALPROLIX	Orphan Designation	-
moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome	ALPROLIX	Orphan Designation	-
periodic fever-infantile enterocolitis-autoinflammatory syndrome	ALPROLIX	Orphan Designation	-
peripheral primitive neuroectodermal tumor	ALPROLIX	Orphan Designation	-
pheochromocytoma	ALPROLIX	Orphan Designation	-
sitosterolemia 1	ALPROLIX	Orphan Designation	-

← Back to Companies